OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,809,000 | -15.1% | 574,555 | -30.3% | 0.00% | 0.0% |
| Q3 2016 | $5,664,000 | +47.5% | 824,426 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $3,839,000 | -43.5% | 775,611 | +10.2% | 0.00% | -50.0% |
| Q1 2016 | $6,798,000 | +4.6% | 703,729 | +1.5% | 0.00% | +100.0% |
| Q4 2015 | $6,497,000 | +17.7% | 693,409 | +76.7% | 0.00% | 0.0% |
| Q3 2015 | $5,518,000 | -24.0% | 392,453 | +13.6% | 0.00% | -50.0% |
| Q2 2015 | $7,262,000 | +6.7% | 345,336 | +113.0% | 0.00% | 0.0% |
| Q1 2015 | $6,806,000 | +83.5% | 162,100 | +2.8% | 0.00% | +100.0% |
| Q4 2014 | $3,710,000 | +75.1% | 157,739 | +11.4% | 0.00% | 0.0% |
| Q3 2014 | $2,119,000 | – | 141,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |